Collier David J

CIK 00013408866 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001340886

Recent Transactions

50 trades

Sale
VYNE Therapeutics Inc.$VYNE
Common Stock
2018-07-24$7.65/sh−487,500→ 1,907,568 total
Sale
VYNE Therapeutics Inc.$VYNE
Common Stock
2018-07-24$7.65/sh−12,500→ 48,910 total
Other
VYNE Therapeutics Inc.$VYNE
Common Stock
2018-03-02+152,062→ 152,062 total
Conversion
VYNE Therapeutics Inc.$VYNE
Common Stock
2018-01-29+127,269→ 2,395,068 total
Conversion
VYNE Therapeutics Inc.$VYNE
Series C Preferred Stock
2018-01-29−21,789→ 0 total
Conversion
VYNE Therapeutics Inc.$VYNE
Series A Preferred Stock
2018-01-29−6,971→ 0 total
Conversion
VYNE Therapeutics Inc.$VYNE
Common Stock
2018-01-29+2,584→ 1,418,005 total
Conversion
VYNE Therapeutics Inc.$VYNE
Common Stock
2018-01-29+849,794→ 2,267,799 total
Conversion
VYNE Therapeutics Inc.$VYNE
Series B Preferred Stock
2018-01-29−58,777→ 0 total
Conversion
VYNE Therapeutics Inc.$VYNE
Series B Preferred Stock
2018-01-29−2,292,320→ 0 total
Conversion
VYNE Therapeutics Inc.$VYNE
Series C Preferred Stock
2018-01-29−343,310→ 0 total
Conversion
VYNE Therapeutics Inc.$VYNE
Common Stock
2018-01-29+66→ 36,358 total
Conversion
VYNE Therapeutics Inc.$VYNE
Series A Preferred Stock
2018-01-29−179→ 0 total
Conversion
VYNE Therapeutics Inc.$VYNE
Common Stock
2018-01-29+21,789→ 58,147 total
Conversion
VYNE Therapeutics Inc.$VYNE
Common Stock
2018-01-29+3,263→ 61,410 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-20$9.88/sh−8,327→ 1,559,995 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-20$9.88/sh−213→ 39,998 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-19$10.03/sh−7,097→ 1,568,322 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-19$10.03/sh−182→ 40,211 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-18$10.10/sh−4,434→ 1,575,419 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-18$10.10/sh−114→ 40,393 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-15$10.32/sh−7,020→ 1,579,853 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-15$10.13/sh−10,735→ 1,586,873 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-15$10.32/sh−180→ 40,507 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-15$10.13/sh−275→ 40,687 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-14$10.32/sh−12,675→ 1,597,608 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-14$10.27/sh−13,714→ 1,610,283 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-14$10.32/sh−325→ 40,962 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-14$10.27/sh−352→ 41,287 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-13$10.16/sh−12,375→ 1,623,997 total
Sale
Neos Therapeutics, Inc.
Common Stock
2016-04-13$10.16/sh−317→ 41,639 total
Conversion
Neos Therapeutics, Inc.
Common Stock
2015-07-28+162,500→ 1,246,372 total
Conversion
Neos Therapeutics, Inc.
Common Stock
2015-07-28+677,622→ 1,083,872 total
Conversion
Neos Therapeutics, Inc.
Series C Preferred Stock
2015-07-28−10,000→ 0 total
Conversion
Neos Therapeutics, Inc.
Series C Preferred Stock
2015-07-28−390,000→ 0 total
Conversion
Neos Therapeutics, Inc.
Common Stock
2015-07-28+4,166→ 1,278,328 total
Conversion
Neos Therapeutics, Inc.
Common Stock
2015-07-28+10,416→ 1,256,788 total
Conversion
Neos Therapeutics, Inc.
Series C Preferred Stock
2015-07-28−41,700→ 0 total
Conversion
Neos Therapeutics, Inc.
Common Stock
2015-07-28+406,250→ 406,250 total
Conversion
Neos Therapeutics, Inc.
Series B Preferred Stock
2015-07-28−25,000→ 0 total
Conversion
Neos Therapeutics, Inc.
Series C Preferred Stock
2015-07-28−1,626,294→ 0 total
Conversion
Neos Therapeutics, Inc.
Series B Preferred Stock
2015-07-28−975,000→ 0 total
Conversion
Neos Therapeutics, Inc.
Common Stock
2015-07-28+17,374→ 1,274,162 total
Exercise of In-Money
Neos Therapeutics, Inc.
Preferred Stock Warrant (Right to Buy)
2015-07-27−10,000→ 0 total
Exercise of In-Money
Neos Therapeutics, Inc.
Preferred Stock Warrant (Right to Buy)
2015-07-27−390,000→ 0 total
Sale
INTERMOLECULAR INC
Common Stock
2014-11-10$2.20/sh−104,342→ 0 total
Sale
INTERMOLECULAR INC
Common Stock
2014-11-10$2.20/sh−4,376,913→ 0 total
Sale
CODEXIS, INC.$CDXS
Common Stock
2014-11-10$2.37/sh−2,740,158→ 0 total
Sale
CODEXIS, INC.$CDXS
Common Stock
2014-11-10$2.37/sh−181,067→ 0 total
Sale
TETRAPHASE PHARMACEUTICALS INC
Common Stock
2013-09-18$10.20/sh−2,335→ 47,992 total

Companies

Recent Filings

Address

ONE EMBARCADERO CENTER, SUITE 3250

SAN FRANCISCO, CA, 94111

View on SEC.gov